Back to all compounds

Swipe to change view · pinch to zoom

BPC-157 5 mg lyophilized research peptide vial, PRIMEGEN LABS front label. Buy BPC-157 5 mg from PrimeGen Labs — 99.4% purity lyophilized BPC-157 peptide for laboratory research, third party tested by HPLC and mass spectrometry, supplied in a sealed 10 mL borosilicate vial with a batch-matched certificate of analysis.

Best sellerRecovery Research

BPC-157

Pentadecapeptide

Synthetic 15-amino-acid sequence derived from gastric juice protein, widely studied in tissue-repair models.

In stock

Quantity

1

Price

$35.00

Shipping & delivery

  • United States onlyDispatched from our US facility in Chase City, Virginia.
  • 10–12 business daysLyophilized material is ambient-stable in protective, discreet packaging.
  • Tracking after dispatchA tracking number is emailed once your order ships.

Shipping costs are calculated at checkout. Full shipping information · Refund & damage policy

At a glance

  • Third-Party Tested
  • Lot-matched documentation
  • HPLC purity data (99.857%)
  • Ambient-Stable Transit
  • Lot Traceable
  • Tracked Delivery
  • Research Use Only
  • Ships from United States

Key facts

BPC-157 5 mg is a lyophilized research peptide supplied by PrimeGen Co. (vial branded PRIMEGEN LABS) for laboratory research use only. Synthetic 15-amino-acid sequence derived from gastric juice protein, widely studied in tissue-repair models. Each lot is RP-HPLC assayed at 99.857% purity with a lot-matched certificate of analysis available digitally. It is not a drug, supplement, or cosmetic and is not for human or veterinary use.

Compound:
BPC-157 5 mg
Strength:
5 mg
Purity (RP-HPLC):
99.857%
Form:
Lyophilized powder, sealed vial
Verification:
Third-party HPLC & MS
Price:
$35.00 USD
Storage:
-20 °C sealed · 2–8 °C after reconstitution
Ships from:
United States
Shipping:
United States only · 10–12 business days
Certificate of analysis:
Lot-matched COA available
Intended use:
Laboratory research use only
Stock status:
In stock

BPC-157 is catalogued under Research Peptides and Recovery Research. Each lot ships with third-party certificate of analysis documentation, is released against our quality control process, and is dispatched from southern Virginia — see shipping information and the FAQ before ordering.

For laboratory research use only. Not for human or veterinary consumption.

Laboratory specifications

Purity (RP-HPLC)
99.857%
Molecular formula
C62H98N16O22
Molecular weight
1419.53 g/mol
Sequence
GEPPPGKPADDAGLV
CAS number
137525-51-0
Form
Lyophilized powder
Appearance
White to off-white lyophilized powder or cake, free of visible particulates.
Solubility
Sterile or bacteriostatic water; DMSO for hydrophobic sequences
Endotoxin
< 0.25 EU/mg
Fill weight
5 mg
Storage temperature
-20 °C sealed · 2–8 °C after reconstitution
Shelf life
36 months at -20 °C from the manufacture date
Reconstitution
Add diluent slowly down the vial wall; do not shake or vortex
Synthesis
Solid-phase (SPPS)
Identity
ESI-MS confirmed
Residual solvent
< 0.5%
Closure
Crimped aluminium / butyl stopper
Distributed by
PrimeGen Co.

Storage & handling

  • Long-term

    -20 °C, sealed, desiccated

  • In transit

    Ambient stable up to 21 days

  • After reconstitution

    2–8 °C, use within 21 days

  • Light exposure

    Protect from direct light

Certificate of analysis

Janoshik Analytical report #109944 · sample submitted as BPC-157 10 mg.

Lot number
XX
EXP
XX/XXXX
COA date
19 Feb 2026
Testing laboratory
Janoshik Analytical
Purity
99.857%
Testing method
RP-HPLC + ESI-MS
Batch status
Released
Measured content
11.48 mg
Verification key
YDP8ZHMBY4K7
Page one of the Janoshik Analytical certificate of analysis for BPC-157 5 mg, report #109944, showing 99.857% purity
Janoshik Analytical report #109944 · analyzed 19 Feb 2026 · 99.857% purity. Tap to open the full PDF.

Scientific overview

Research summary: Synthetic 15-amino-acid sequence derived from gastric juice protein, widely studied in tissue-repair models.

BPC-157 is a synthetic 15-residue sequence derived from a partial region of body protection compound, a protein isolated from gastric juice. It is one of the most widely cited peptides in experimental tissue-repair literature, largely because of its unusual stability in aqueous and acidic environments.

Mechanism of action

Preclinical reports associate the sequence with upregulation of vascular endothelial growth factor receptor 2 and downstream activation of the VEGFR2-Akt-eNOS pathway, together with modulation of nitric oxide tone and focal adhesion kinase-paxillin signalling in fibroblast migration assays. No specific high-affinity receptor has been identified.

Areas of scientific investigation

  • Angiogenesis and endothelial tube-formation assays
  • Fibroblast migration and tendon-cell outgrowth models
  • Gastrointestinal mucosal integrity research
  • Nitric oxide system and vascular tone studies

Listed fields describe where this sequence appears in published in vitro and preclinical literature. They are not indications, applications, or claims of effect.

Laboratory handling

Reconstitution

Allow the vial to reach room temperature before opening to prevent condensation on the lyophilized cake. Add sterile or bacteriostatic water slowly down the inner wall of the vial, then let the powder dissolve without agitation; swirl gently if needed. Do not shake or vortex — shear forces denature peptide secondary structure and cause foaming that traps material on the stopper.

Stability

Notably robust in solution relative to comparable short peptides; literature reports retained integrity in aqueous media across a wide pH range, which is why it is often selected for gastric-environment models.

Packaging

Single sequence per vial, sealed under inert gas in USP Type I borosilicate glass with a butyl rubber stopper and crimped aluminium overseal. Each vial carries a printed PrimeGen label with product name, strength, lot number, manufacture and retest dates, storage temperature and a QR code linking to the lot record. Vials ship in a rigid foam insert inside a protective mailer at ambient temperature.

Research use only

For laboratory research purposes only. Not intended for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Purchasers are responsible for complying with all applicable laws and regulations.

BPC-157 5 mg — laboratory research dossier

This dossier collects everything a laboratory typically needs before requisitioning BPC-157 at the 5 mg presentation: how the sequence is characterised in published literature, how the material is assayed and released, how it should be stored and reconstituted, and where it sits inside the wider recovery research catalogue. Every unit is supplied as a sealed lyophilized powder at 99.4% and is sold exclusively for laboratory research use. It is not a drug, dietary supplement or cosmetic, and it is not intended for human or veterinary use.

Scientific background

BPC-157 is a synthetic 15-residue sequence derived from a partial region of body protection compound, a protein isolated from gastric juice. It is one of the most widely cited peptides in experimental tissue-repair literature, largely because of its unusual stability in aqueous and acidic environments.

Synthetic 15-amino-acid sequence derived from gastric juice protein, widely studied in tissue-repair models. Investigators most often encounter this sequence in angiogenesis and endothelial tube-formation assays and in fibroblast migration and tendon-cell outgrowth models, which is why the 5 mg vial is the format we release most frequently — it gives enough material for a full dose-response series at typical assay concentrations without leaving a large reconstituted surplus to store. This compound is catalogued at 3 strengths (5 mg, 10 mg, 20 mg), so a study can be scaled without changing lot chemistry.

Mechanism of action in published work

Preclinical reports associate the sequence with upregulation of vascular endothelial growth factor receptor 2 and downstream activation of the VEGFR2-Akt-eNOS pathway, together with modulation of nitric oxide tone and focal adhesion kinase-paxillin signalling in fibroblast migration assays. No specific high-affinity receptor has been identified.

Descriptions above summarise observations reported in peer reviewed in vitro and animal literature. They describe what has been measured in model systems and are not claims of effect, indications, or guidance for use in humans or animals. Laboratories designing new work should return to the primary literature for concentration ranges, vehicle selection and control design, because reported effects in this class are strongly assay dependent.

Research applications

Published work involving BPC-157 clusters into a small number of recurring experimental settings:

  • Angiogenesis and endothelial tube-formation assays
  • Fibroblast migration and tendon-cell outgrowth models
  • Gastrointestinal mucosal integrity research
  • Nitric oxide system and vascular tone studies

Because these are in vitro and preclinical contexts, the practical requirement on the material itself is consistency: a known mass of a single sequence, a stated purity, and a lot record that can be cited in a methods section. That is what the 5 mg vial and its accompanying certificate of analysis are designed to provide.

Analytical identity and specification

Compound
BPC-157
Presentation
5 mg lyophilized powder, single sequence per vial
Reported purity
99.4% by RP-HPLC
Molecular formula
C62H98N16O22
Molecular weight
1419.53 g/mol
CAS number
137525-51-0
Sequence
GEPPPGKPADDAGLV
Appearance
White to off-white lyophilized powder or cake, free of visible particulates.
Unit price
$35.00 per vial

Purity, quality control and the certificate of analysis

Each BPC-157 lot is assayed in house by reverse-phase HPLC and then re-tested by an independent analytical laboratory using HPLC alongside mass spectrometry for identity confirmation. The HPLC trace establishes the chromatographic purity figure printed on the label — 99.4% for the current release — while the mass spectrometry step confirms that the observed molecular ion matches the expected mass for the sequence rather than a truncated or deletion analogue.

Certificates are issued digitally rather than enclosed in the shipment, which keeps the document versioned and retrievable long after the vial is consumed. You can view or request the current report from the certificates library, and the underlying chromatograms and spectra can be requested through laboratory support. Our full release criteria are documented on the quality control and laboratory standards pages.

Storage, reconstitution and stability

Storage. Sealed 5 mg vials are held desiccated and protected from light. Short holding periods at 2-8 °C are routine; for longer storage the lyophilized cake is kept at -20 °C. Allow the vial to equilibrate to room temperature before breaking the seal so that atmospheric moisture does not condense onto the powder.

Reconstitution. Allow the vial to reach room temperature before opening to prevent condensation on the lyophilized cake. Add sterile or bacteriostatic water slowly down the inner wall of the vial, then let the powder dissolve without agitation; swirl gently if needed. Do not shake or vortex — shear forces denature peptide secondary structure and cause foaming that traps material on the stopper.

Stability. Notably robust in solution relative to comparable short peptides; literature reports retained integrity in aqueous media across a wide pH range, which is why it is often selected for gastric-environment models.

Handling. Work with the reconstituted solution under standard laboratory containment, record the reconstitution volume and date against the lot, and label aliquots with the resulting concentration. Volumes and concentrations are set by your own protocol; nothing on this page is a dosing instruction.

Experimental design considerations

The most common source of irreproducibility with lyophilized peptides is not the sequence itself but the arithmetic around it. A 5 mg vial contains a nominal peptide mass; the actual peptide content of any lyophilized cake also reflects counter-ion and residual moisture content, so laboratories reporting exact molar concentrations should either use the net peptide content figure from the lot certificate or determine content independently by amino acid analysis or quantitative UV. Using the published average mass of 1419.53 g/mol, a full 5 mg vial reconstituted in 1 mL of diluent gives a convenient round stock concentration for serial dilution.

Three practical points recur in method sections for this class of material:

  • Vehicle matters. Record the diluent, its preservative content and its pH alongside the concentration. Bacteriostatic and sterile water are not interchangeable in every assay, and benzyl alcohol can interfere with sensitive cell based readouts.
  • Adsorption is real. At low working concentrations, peptides adsorb to polypropylene and glass. Low-bind labware or a carrier protein in the dilution buffer keeps the delivered concentration close to the nominal one.
  • Cite the lot. Because purity, counter-ion and net content vary between syntheses, methods sections should name the supplier lot for BPC-157 so a later replication can be matched to the same analytical record.

Where a study spans several weeks, aliquoting the reconstituted stock immediately and freezing single-use volumes avoids the freeze-thaw cycling that accounts for most of the potency drift observed in longitudinal work.

Choosing the right presentation

BPC-157 is released at 5 mg, 10 mg, 20 mg. Larger presentations lower the cost per milligram but commit a laboratory to using or storing more reconstituted material; smaller vials suit pilot work, method development and screening plates where a single stock is consumed quickly. The 5 mg vial listed on this page is priced at $35.00. Whatever presentation you select, the underlying material comes from the same synthesis and release programme, so switching strength does not change the analytical profile.

Orders ship from our facility in Chase City, Virginia, within the United States only, and every shipment carries the research use restriction on the outer documentation. Vials travel at ambient temperature in a rigid insert; lyophilized peptide is stable for the transit window, and the material should be moved to its long term storage temperature on arrival. Research materials are non returnable once dispatched.

Related research compounds and documentation

Laboratories sourcing BPC-157 frequently reference TB-500 5 mg, GHK-Cu 50 mg, KPV 5 mg and Thymosin Beta-4 2 mg alongside it, either as comparators in the same assay or as adjacent sequences in the same pathway literature.

This compound is catalogued under Research Peptides, Recovery Research. The complete research compound catalogue lists every sequence and strength we hold.

BPC-157 also appears in lot matched research kits: Recovery Research Stack, Wolverine Stack, Wolverine Stack (Copper-Free), which ship as a single release window so comparative work is not split across lots.

Background reading in the research library: What are research peptides?, Understanding lyophilized powders, Are research peptides legal to buy online?.

Ordering details, transit times and our US shipping guarantee are set out on the shipping policy page, and general purchasing and compliance questions are answered in the frequently asked questions. Terms of sale, including our no returns policy on research materials, are published on the terms page.

Quality programme and laboratory support

Every BPC-157 release passes through the same programme: synthesis against a defined sequence, in-house RP-HPLC purity assay, independent third party HPLC and mass spectrometry confirmation, visual inspection of the lyophilized cake, and a documented fill and seal step under inert gas in USP Type I borosilicate glass. Material that fails any stage is not released, and the certificate published for a lot is the certificate generated for that specific synthesis — never a representative or historical document carried over from an earlier batch.

Laboratories evaluating BPC-157 for the first time frequently ask for the raw analytical files rather than the summary certificate. Chromatograms, mass spectra and, where applicable, net peptide content data can be requested for any lot; our support team answers analytical questions directly rather than through a ticket queue. Institutional purchasing, repeat supply for multi-month studies and quotations for multiple strengths are handled the same way.

Terminology used on this page

Lyophilized
Freeze dried under vacuum. Removing water as vapour rather than liquid leaves a porous cake that dissolves quickly and is far more stable in storage than a peptide held in solution, which is why BPC-157 is supplied this way rather than pre-reconstituted.
RP-HPLC purity
Reverse-phase high performance liquid chromatography separates the target sequence from synthesis-related impurities by hydrophobicity. The reported figure — 99.4% for this material — is the target peak area as a percentage of total integrated peak area.
Mass spectrometry confirmation
An orthogonal identity check. Purity alone cannot distinguish the correct sequence from a co-eluting analogue of similar hydrophobicity; measuring the molecular ion against the expected 1419.53 g/mol confirms that the peak being integrated is the intended molecule.
Net peptide content
The fraction of the vial mass that is peptide rather than counter-ion or residual water. It is the figure to use when converting a 5 mg fill into an exact molar stock concentration.
Research use only
The material is sold for in vitro and laboratory investigation by qualified personnel. It is not a medicine, supplement, food or cosmetic, carries no approval for human or veterinary administration, and must be handled under the purchasing institution’s own safety procedures.

Literature and further reading

The characterisations summarised above are drawn from peer reviewed in vitro and preclinical publications indexed in PubMed and from the corresponding entries in ChEMBL, PubChem and UniProt. Searching the compound name “BPC-157 or CAS 137525-51-0 in those databases returns the primary sources for the mechanism and application notes on this page. PrimeGen Co. does not publish clinical data and makes no therapeutic claim for this or any other catalogue item.

For laboratory research use only. Not for human or veterinary use. Not a drug, supplement, food or cosmetic. Read our research use policy before ordering.

Frequently asked questions

What is included with each BPC-157 vial?

Each unit contains 5 mg of lyophilized BPC-157 in a sealed vial. The lot matched certificate of analysis is available digitally on the Certificates page and is not physically enclosed in the shipment.

How is purity verified?

Every lot is assayed in house by RP-HPLC and then re-tested by an independent laboratory using HPLC and mass spectrometry. This lot reports 99.4%.

How should the vial be reconstituted?

Reconstitution parameters depend on your protocol. Use bacteriostatic or sterile diluent, add slowly against the vial wall, and swirl rather than shake to avoid shearing the peptide.

Can I request the raw analytical data?

Yes. Chromatograms and MS spectra for any lot can be requested through the certificates page or by contacting the laboratory support team.

Is BPC-157 intended for human use?

No. BPC-157 is supplied strictly as a laboratory research chemical. It is not a drug, dietary supplement, or cosmetic, it is not approved for human or veterinary use, and it must not be administered to humans or animals.

How should BPC-157 be stored before and after reconstitution?

Sealed 5 mg vials are held desiccated, protected from light, and away from repeated temperature swings; 2-8 °C suits short holding periods while -20 °C is used for longer storage of the lyophilized cake. Once reconstituted, the solution is normally kept at 2-8 °C for near-term work or aliquoted into single-use volumes and frozen, since repeated freeze-thaw cycling is the most common cause of measurable potency loss.

How much material is in one BPC-157 vial?

Each vial is filled to a nominal 5 mg of lyophilized peptide, with a published average molecular weight of 1419.53 g/mol. Because lyophilized peptide also carries counter-ion and residual moisture, laboratories reporting exact molar concentrations should use the net peptide content on the lot certificate or determine content independently.

What analytical methods are used to release a BPC-157 lot?

Every lot is assayed in house by reverse-phase HPLC for chromatographic purity, then re-tested by an independent laboratory using HPLC alongside mass spectrometry to confirm that the observed mass matches the expected sequence rather than a truncated or deletion analogue. The release specification is ≥ 98% by RP-HPLC; this lot reports 99.4%.

Does BPC-157 ship internationally?

No. Orders ship within the United States only, dispatched directly from our facility in Chase City, Virginia. Vials travel at ambient temperature in a rigid protective insert, and the lyophilized powder is stable across the transit window; move the material to its long-term storage temperature on arrival.

Can BPC-157 be returned or exchanged?

No. Research materials are non-returnable once dispatched, because chain-of-custody and storage conditions cannot be verified after a vial leaves the facility. If a shipment arrives damaged or a lot does not match its certificate of analysis, contact laboratory support and we will resolve it directly.

Complete your order

Laboratory consumables matched to 1 vial in your cart.

  • Bacteriostatic Water, 30 mL, laboratory consumable supplied by PrimeGen Co.

    Bacteriostatic Water

    30 mL

    1 × 30 mL — one vial of diluent per 3 peptide vials

    $16.00
  • Sterile Syringes, 10-pack · 1 mL, laboratory consumable supplied by PrimeGen Co.

    Sterile Syringes

    10-pack · 1 mL

    10-pack covers a standard order

    $13.00
  • Alcohol Prep Pads, 100-pack, laboratory consumable supplied by PrimeGen Co.

    Alcohol Prep Pads

    100-pack

    Septum decontamination before every draw

    $9.00
  • Vial Storage Case, 25 slots, laboratory consumable supplied by PrimeGen Co.

    Vial Storage Case

    25 slots

    Keeps lots organised and light-protected

    $33.00

Research stacks

Stacks that include BPC-157

  • Recovery Research Stack

    BPC-157 5 mg · TB-500 10 mg · DSIP 5 mg

    View stack
  • Wolverine Stack

    BPC-157 10 mg · TB-500 10 mg · GHK-Cu 50 mg

    View stack
  • Wolverine Stack (Copper-Free)

    BPC-157 10 mg · TB-500 10 mg

    View stack

Other compounds catalogued alongside BPC-157 in Recovery Research. All items are supplied for laboratory research use only.

View Recovery Research

Explore further

Continue from BPC-157 into compounds studied alongside it, the kits that include it, the analytical documentation behind this lot, and the library articles covering its category.

BPC-157 · 5 mg

In stock

$35.00